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ORIGINAL RESEARCH
Introduction: Prevention of medication errors is a priority for health services worldwide.
Pharmacists routinely screen prescriptions for potential problems, including prescribing errors.
This study describes prescribing problems reported by community pharmacists and discusses
them from an error prevention perspective.
Method: For one month, nine community pharmacists documented prescribing problems,
interventions made, and the proximal causes of the problems. The results were presented to
local GPs and pharmacists at a meeting and feedback was invited.
Results: For 32 403 items dispensed, pharmacists reported 196 prescribing problems (0.6%).
The reporting rates ranged from 0.2%–1.9% between pharmacists and were inversely correlated
to dispensing volume. Prescriptions containing incomplete or incorrect information accounted
for two-thirds of the problems. Lack of information on the prescriptions and transcribing/
typing errors were the most frequently cited proximal causes. A few pitfalls of computerized
prescribing were observed.
Conclusion: Although rates of prescribing problems reported were relatively low, community
pharmacists and patients remain important safeguards. This study identified potential causes
of prescribing errors, and illustrated areas which could be improved in the design of
computerized prescribing systems, and the communication and sharing of information between
GPs and pharmacists.
Keywords: prescribing errors, general practice, community pharmacy
Introduction
Prevention of medication errors has been recognized as a priority in health care
systems worldwide, as exemplified in the publication of the Institute of Medicine,
USA’s report To err is human (Kohn et al 1999) and the document An organisation
with a memory (Department of Health 2000) by the Department of Health, UK.
Multiple defensive mechanisms are required in a complicated healthcare system to
achieve this goal (Reason 2000). Prevention of errors at the prescribing stage is one
of the important steps towards reducing medication errors. Although prescribing
errors have been systematically studied in hospitals (Leape et al 1995; Lesar et al
1997; Dean et al 2002), similar information derived from primary care settings is
scant.
Community pharmacists routinely screen prescriptions for potential problems,
including prescribing errors, before the drugs are dispensed. They are in an ideal
position to identify, record, rectify, and prevent prescribing errors.
Prescribing problems have been classified as errors of omission and errors of
commission, which require reactive and proactive interventions, respectively, by
pharmacists to rectify them (Rupp 1991). This classification, based on the factual
presentation of the prescribing problems, is useful for differentiating problems which
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are overt and less likely to cause harm (errors of omission)
from those which are not always obvious and are potentially
more dangerous. However, not all prescribing problems arise
from errors, and this warrants further clarification when
prevention of prescribing errors is to be considered.
As illustrated in Figure 1, some prescribing problems
are caused by errors, which can occur at different stages:
those occurring at decision-making are termed mistakes,
while those happening during prescription-generation can
be caused by either slips (doing something different from
the initial intention; for example, writing methotrexate
7.5 mg daily instead of weekly), or lapses (forgetting to do
something as intended such as signing the prescription).
These errors are theoretically preventable and are the focus
of error prevention strategies. Other prescribing problems
can arise from the inherent risk of drug therapy or the process
associated with the supply and reimbursement of the
medications. While these problems do not represent errors
in the first instance, they can be regarded as errors if they
are not recognized and are repeated in subsequent
prescriptions. Sometimes, problems may arise from
prescribers’ intentional violation of guidelines or rules (for
example, prescribing propranolol in response to a strong
request by a patient despite knowing he or she has a history
of asthma).
Although several studies have documented community
pharmacists’ interventions on prescribing problems (Jones
1978; Rupp et al 1992; Fielding et al 1993–1994; Greene
1995a, 1995b; Claesson et al 1995; Caleo et al 1996;
Hawksworth et al 1999; Shah et al 2001; van Mil et al 2001;
Westein et al 2001; Quinlan et al 2002; Benrimoj et al 2003a,
2003b), most of them have focused on the recognition,
documentation, and resolution of prescribing problems and
have not addressed these problems from a preventive
perspective.
Based on the framework shown in Figure 1 and discussed
above, the objectives of this paper are to describe prescribing
problems reported by community pharmacists, and to
discuss these problems from an error-prevention perspective.
Method
Definition of prescribing problems
Prescribing problems in this study were defined as any
problems identified in the process of dispensing that might
(1) interfere with the dispensing of prescriptions, such as
incomplete prescriptions and prescriptions with incorrect
information; or (2) be potentially harmful to the patients,
such as potentially hazardous drug–drug interactions,
inappropriate doses or directions, contraindications, adverse
drug reactions, allergy to drugs, and drug duplications. As
prescribing problems cover a wide range of unsatisfactory
situations varying in their importance and potential impact,
the use of this definition allowed pharmacists to record only
those problems that have impact on medication safety or on
the efficiency of dispensing.
Study participation
All eleven community pharmacies in an area of Nottingham,
England were invited to participate in this study. One
pharmacy declined due to a heavy workload and lack of
interest, and another was unable to participate because there
was no full-time pharmacist. The remaining nine pharmacies
agreed to participate. These participating pharmacies
included two independent pharmacies, three local multiples,
three regional multiples (with 10–50 branches), and a large
nationwide chain pharmacy.
Data collection
A data collection form was designed and distributed to all
participating pharmacies in January 2000. It was piloted in
one participating pharmacy for one month and in the other
pharmacies for one week. This data collection form was
revised according to the feedback from the pharmacists and
the final data collection form used in the study is available
from the authors.
Formal data collection started in April 2000 and finished
at the end of January 2001. Each of the participating
pharmacies was allocated one month during this period to
collect data. It was envisaged that most pharmacies would
be extremely busy in December, and so none of the
Prescribing problems
Errors in 
prescribing 
decision
making
(mistakes)
Errors in 
generating 
prescriptions 
(slips and lapses) 
Inherent risk and 
uncertainty of drug 
therapy
Prescribing
errors
Violations
Adverse drug events
If not 
recognized
Contributing
Potentially contributing
Problems related 
to drug supply 
and payment
Prescribing problems
Errors in 
prescribing 
decision
making
(mistakes)
Errors in 
generating 
prescriptions 
(slips and lapses) 
Inherent risk and 
uncertainty of drug 
therapy
Prescribing
errors
Violations
Adverse drug events
If not 
recognized
Contributing
Potentially contributing
Problems related 
to drug supply 
and payment
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pharmacies were asked to collect data during this month.
Data collected in this study included:
￿ The dates when problematic prescriptions were
presented to the pharmacists
￿ Age and gender of the patients
￿ Brief descriptions of the problems
￿ Interventions made by the pharmacists
￿ Estimated time the pharmacists spent dealing with these
problems.
The pharmacists were asked to code the origin of the
prescription (local practices, other practices, dentists, or
hospital), type of problem, intervention made, and proximal
causes of the problems according to the coding list provided
with the data collection form. The proximal causes were
adapted from Leape et al (1995) and were defined as “the
apparent reasons for the prescribing problems; they are
broad categories that are useful for focusing further inquiry
and may not be true causes”. Prescribing problems were
recorded whether the prescriptions were eventually
dispensed or not.
Data validation and coding
One of the investigators (Yen-Fu Chen) visited the
participating pharmacies at least once a week during their
data collection month to collect prescribing problems that
were being recorded, to obtain incomplete information
whenever possible, and to clarify any queries regarding data
collection and coding. As the majority of the reported
problems turned out to be in the “incomplete/incorrect/
illegible prescriptions/product unavailable” category, these
problems were further classified by the investigator after
data collection.
As part of data validation, a sample of prescriptions
dispensed by each pharmacy during the data collection
month was screened for potentially hazardous drug
combinations by the investigator using a standard drug
interaction computer program. This also allowed the
collection of additional information on potentially hazardous
drug combinations which has been described elsewhere
(Chen et al 2002).
Ethical approval and confidentiality of
the data
Ethical approval for this study was obtained from the local
research ethics committee. No identifiable information (such
as names and addresses) on prescriptions was recorded, and
information on potentially hazardous drug combinations was
fed back to the participating pharmacists.
Data analysis
Descriptive statistics were computed by the Statistical
Package for the Social Sciences (Release 9.0) software.
Pearson’s correlation coefficient was used to examine the
relationship between dispensing volume and prescribing
problems reported.
Feedback from local pharmacists and
general practitioners
The results of the study were presented to local GPs and
pharmacists at a meeting. Feedback was invited from the
participants of the meeting concerning data collection,
causes of the prescribing problems, possible preventive
measures, and solutions. Relevant comments were used to
inform the discussion section of this paper. Since it was not
our intention to carry out a qualitative study, no formal
qualitative research methods were used during the collection
and analysis of the data from the meeting.
Results
Problem reporting rate
Overall, 32 403 items were dispensed by the participating
pharmacies during the data collection months. The
pharmacists reported 201 prescribing problems, representing
a reporting rate of 0.6% (6 prescribing problems reported
per 1000 items dispensed). Five of these were ruled to be
outside the scope of this study: four of them involved GPs
asking for information on medications or their usage before
or during prescribing, and one related to dispensed
controlled drugs not being collected by the patient. They
have therefore been excluded from all subsequent analysis.
The 196 remaining prescribing problems related to 194
prescriptions (two had two problems).
The reporting rate varied substantially between
pharmacies, ranging from 0.2%–1.9% (see Figure 2). There
was a negative correlation between dispensing volume and
reporting rate (Pearson’s correlation coefficient –0.69,
p = 0.041), and the two pharmacies with lowest dispensing
volume had highest reporting rate.
As shown by Figure 3, the number of prescribing
problems reported by the pharmacists for each general
practice (or area) correlates well with the number of items
dispensed in the study area (Pearson’s correlation coefficientTherapeutics and Clinical Risk Management 2005:1(4) 336
Chen et al
0.94, p < 0.001). Problem rates ranged from 0.4%–1.6% for
the practices or areas. Only a small number of prescriptions
from hospitals were dispensed and no problem was reported
for these prescriptions.
Types of prescribing problems
The types of problems and frequency reported by the
community pharmacists are summarized in Table 1, along
with some examples. The majority of prescribing problems
arose from prescriptions having incomplete or incorrect
information, or the prescribed items being not available.
These represent 67% (131/196) of all problems reported.
Potentially hazardous drug combinations were reported in
17 cases (9%), followed by inappropriate direction/
instruction in 15 cases (8%). Each of the remaining types
of problems accounted for 5% or less of overall problems.
Interventions made by pharmacists
The pharmacists obtained additional information from the
patients and pharmacy medication records and resolved 21%
(41/196) of the problems without any contact with the
general practices. More than half of the problems concerning
potential drug interactions, adverse drug reactions,
inappropriate directions, and missing quantities were dealt
with in this way.
In 29% (57/196) of cases, the pharmacists made their
own decision to dispense the medication, but the prescription
had to be returned to the surgery for alteration. The majority
of these involved unsigned prescriptions, prescriptions
lacking endorsement by a GP to conform to regulatory/
administrative requirements, and incorrect pack size.
Receptionists were contacted for 17% (33/196) of the
prescribing problems and prescribing GPs for a further 26%
(50/196). Two-thirds (33/50) of contacts with GPs resulted
in changes to prescriptions. Patients were referred back to
their GP for 5% (9/196) of the problems.
Overall the participating pharmacists estimated spending
an average of 5.7 minutes per problem (minimum 0.2,
median 5, maximum 48). This is equivalent to approximately
half an hour per week for each pharmacy.
Proximal causes of prescribing
problems
The pharmacists were asked to suggest proximal causes for
each prescribing problems that they identified. The most
frequent two proximal causes for each type of problem are
listed in Table 1. Lack of information on the prescription
was cited most frequently and accounted for 31% (60/196)
of all prescribing problems. The missing information
involved various parts of a prescription, including signature,
strength, quantity, product information (for dressings or
devices), and endorsement required for certain drugs such
as SLS (Selected List Scheme) for sildenafil. In most cases,
it was not possible to ascertain the true underlying reason
for the omission of information.
Transcribing/typing errors were thought to be associated
with 23% (30/196) of the reported problems. They were the
major cause suggested for incorrect prescriptions. Examples
include inappropriate directions, instructions, or doses, such
as “Fucithalmic 2 hourly” instead of twice daily, and
“simvastatin 1 o.m.” (in the morning) instead of “1 o.n.” (at
night); incorrect strength or dosage form, such as writing
“Co-amoxiclav 250/62 tablets” while the correct strength
for tablets is 250/125 and for suspension is 250/62; and
incorrect quantities, such as “Gaviscon® 1 ml” or “Diastix®
0 strip”. Errors in transcribing messages from hospitals were
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Figure 3 Prescribing volume and number of prescribing problems reported for
each general practice or area. Keys: 1–7: local practices; Nottingham: other
practices in the Nottingham Health Authority; Derby: practices in the
Derbyshire (neighbouring) Health Authority; Other: other health authorities and
dental practices; Hospital: local hospitals
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Figure 2 Relationship between pharmacy dispensing volume and problem
reporting rate.
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Table 1 Type, frequency, and proximal causes of prescribing problems reported by community pharmacists
Two most frequent
proximal causes
(frequency – multiple
Frequency causes allowed for
Type of problem (total %) Explanation and examples (frequency) each problem)
1. Incomplete/incorrect/ 131 (67%) These problems resulted in one or more of the following Lack of information on the
illegible prescription/ product situations: prescribed items could not be dispensed; prescribed prescription (60),
unavailable items could not be reimbursed correctly; prescribed items or the transcribing/typing errors
patient on the prescriptions differed from what the prescribing (30)
doctor intended or the patient expected
Incomplete prescription: 53 (27%) Lack of signature on the prescription (26); missing strength (5); Lack of information on the
no signature; lack of quantity (7); or dosage direction (1); insufficient information on prescription (52), problems
other information or dressings or devices (4); doctor’s endorsement (for regulatory or involving repeat prescribing
required endorsement administrative purposes) missing, such as SLS (Selected List system (11)
Scheme) required for the prescribing of sildenafil (4); insufficient
information on similar preparations (2); no practice address (1);
brand name not specified for modified-release preparation (1);
insufficient information on the formula of the preparation (1)
Incorrect prescription: 66 (34%) Incorrect pack size or quantity (19): these particularly involved Transcribing/typing errors
wrong information female sex hormones (combined contraceptive pills and hormone (28), lack of knowledge of
concerning medication, replacement therapy), test strips, and non-oral preparations such the drug (14)
pack size/quantity, or as eye drops, skin preparations, and insulin injection equipment.
patient; violation of Incorrect or inappropriate dosage forms (18): these related to the
legal requirements prescribing of a dosage form which was different from what the
patient was using (and thus expected to receive). Some cases
involved patients having difficulty in using the dosage form while
others related to patient’s special needs or preferences. Inhalers
and modified release dosage forms were recorded in three cases
each (modified release form intended but appropriate suffix such
as “SR” or “XL” not specified). Other types of incorrect
prescriptions included wrong drug (6), wrong device (6), wrong
strength (5), wrong patient name or address (5), wrong size (2),
wrong brand (2), violation of legal requirement for controlled
drugs (2), and incorrect spelling (1)
Others 12 (6%) Product unavailable (6), not prescribable under the National Drug stocking and supply 
Health Services (3), illegible dosage (2), and faint printing (1) problems (10), poor
legibility of the
prescription (3)
2. Regular item missing  4 (2%) This related to problems with the repeat prescribing system and Problems involving repeat
was usually brought up by the patient prescribing system (3),
poor communication (1)
3. Duplication of drug 4 (2%) This type of problem included duplication of the same drug Problems involving repeat
(which may bear different names on the prescription, such as prescribing system (3),
metformin and Glucophage®). It also included possibly transcribing/typing
unintended prescribing of different drugs with the same effects errors (1)
4. Inappropriate dose 9 (5%) This included the prescribing of either excessive or insufficient Lack of knowledge of the
doses. Some examples involved inappropriate directions for the drug (3), no actual
maximum daily dose. Unusually high or low doses prescribed problem (3)
intentionally were also classified into this category because
pharmacists had to query the potentially inappropriate doses for
patient safety unless the intention was confirmed by prescribing
doctors. Four out of nine reported cases in this category
involved prescriptions of antibiotics and paracetamol
(acetaminophen) for children
continuedTherapeutics and Clinical Risk Management 2005:1(4) 338
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Table 1 continued
Two most frequent
proximal causes
(frequency – multiple
Frequency causes allowed for
Type of problem (total %) Explanation and examples (frequency) each problem)
5. Inappropriate 15 (8%) Three possible situations were included in this category: (1) Poor communication (10),
direction/instruction inappropriate directions written on the prescription; (2) lack of knowledge of the
inappropriate instructions given to the patient by the prescribing drug (5)
GP; (3) inconsistency between written directions on the
prescription and instructions understood by the patient
Examples included inappropriate repetition of a previous direction
(such as loading dose for amiodarone or starting dose for
enalapril) on the prescription when it should have been changed
(3); doctors’ instructions on inhalation technique incorrect or
misunderstood (3); directions on the prescription different from
what patient was told or understood (3)
6. Contraindication/ 4 (2%) This type of problem involved prescribing of medications which Lack of knowledge of the
inappropriate drug were not appropriate due to a patient’s age or disease condition. drug (3), no actual
Examples included prescribing peppermint oil (not recommended problem (1)
for children under 15) for a 10-year old child, and prescribing
Cocois
® (scalp ointment, not recommended under 6 years) for a
3-year-old child
7. Adverse drug reaction/ 8 (4%) Suspected adverse drug reactions were brought to the Complications arising from
drug allergy pharmacist’s attention by the patient in seven cases. One patient treatment (2), lack of
with penicillin hypersensitivity was prescribed amoxicillin by information about the
a dentist patient or failure to review
patient’s history (2)
8. Drug interaction 17 (9%) Examples included selective serotonin re-uptake inhibitors (SSRIs) No actual problem (14),
with sumatriptan (2) (increased risk of CNS toxicity), lack of information about
methotrexate with NSAIDs (2) (reduced excretion of the patient or failure to
methotrexate and increased risk of toxicity), and oral review patient’s history (3)
contraceptives – broad-spectrum antibiotics (2) (possibility of
reduced contraceptive effect). GPs were contacted for eight of
the cases. However, the prescribed drugs were altered on only
one occasion
9. Others 4 (2%) In two cases the patients checked the availability of certain Poor communication (2),
medications and then the pharmacists contacted the GP for transcribing/typing
prescriptions. One case was associated with under-treatment of errors (1)
an asthmatic patient, and in another case an item that the patient
needed was crossed off the prescription by practice staff
Total 196 (100%) Lack of information on the
prescription (60),
transcribing/typing
errors (35)
Abbreviations: CNS, central nervous system; NSAIDs, nonsteroidal antiinflammatory drugs.
also observed in this study. In one case, Cacit
® tablets were
prescribed by a GP when the hospital had requested Didronel
PMO
® which contains both Cacit
® tablets and disodium
etidronate tablets. In another case, the transcribing error
resulted in an incorrect dosage instruction. The GP
prescribed risedronate 30 mg 1/2 tablet, but the pharmacist
identified this as inappropriate because the tablet was film
coated and should not be split. It turned out that the hospital
doctor had intended one tablet 1/2 an hour before food. In
another case, a patient needing betamethasone drops was
prescribed a beclomethasone nasal spray possibly due to
the confusion between drug names. In four cases, the
prescription given to the patient had another patient’s name
on it. In three of those cases the patients had similar names.Therapeutics and Clinical Risk Management 2005:1(4) 339
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Seventeen percent (33/196) of the reported problems
related to repeat prescriptions. They include problems of
missing requested items and duplications of the same drug.
Several repeat prescriptions contained incomplete and
incorrect information which may have been carried over
from previous prescriptions.
Lack of knowledge of the drug or product has possibly
contributed to 15% (29/196) of the prescribing problems.
All three cases of inappropriate doses attributable to lack of
knowledge of the drug related to medications for children
under the age of twelve. Interestingly, only one of them
involved an excessive dose whereas the other two involved
doses which were too low. In another three cases, it was
suspected that some patients were given wrong instructions
regarding the technique of using inhalers by a GP.
Poor communication was cited as a possible cause for
twenty-five problems (13%). It was mainly associated with
inappropriate instructions and incorrect drug items or dosage
forms. Poor communication had occurred between different
parties at various stages: between patients and practice
staff (items on the repeat prescriptions were different from
what the patients wanted); between GPs and patients
(inconsistency between GPs’ oral instructions understood
by the patients and the instructions written on the
prescriptions, or GPs not being aware of patients’ problems
in using medications); between hospitals and general
practices (hospital letters misread by GPs or practice staff);
and between pharmacies and general practices (pharmacist’s
written message to GP not heeded).
In 26 cases (13%), the pharmacists acted upon
prescriptions to highlight potential drug-related problems.
No actual errors were presented on these prescriptions.
Fourteen out of seventeen potentially hazardous drug
combinations and three out of nine potentially inappropriate
doses reported by the pharmacists fell into this category.
Discussion
Prescribing problem rate and problem
reporting
Pharmacists in this study reported an overall prescribing
problem rate of 0.6%. This figure is relatively low compared
with the overall rates reported in a number of previous
studies (Rupp et al 1992; Fielding et al 1993–1994; Claesson
et al 1995; Caleo et al 1996; Shah et al 2001), but is very
similar to the result (0.7%) of another study recently done
in the UK (Quinlan et al 2002). Several issues need to be
addressed when comparisons are made between studies.
Firstly, the definition of prescribing problems and errors
differs between studies. In particular, problems relating to
errors of omission (such as indication not specified; Claesson
et al 1995) and reimbursement procedures vary substantially.
When incomplete prescriptions and other procedural
problems are excluded, however, the results between
various studies are fairly consistent (approximately 0.4%)
(Claesson et al 1995; Caleo et al 1996; Hawksworth et al
1999; Quinlan et al 2002). Nevertheless, the potential
problem of underreporting warrants further discussion.
There was a nearly ten-fold variation in the problem
reporting rates among the participating pharmacies in this
study. Differences of this magnitude have been observed in
other studies involving multiple pharmacies (Rupp et al
1992; Greene 1995a; Caleo et al 1996; Hawksworth et al
1999; Benrimoj et al 2003a). The substantial differences
between pharmacies are likely to have arisen from a
combination of many factors, including pharmacists’
experience and perception of prescribing problems, the
incentive for problem reporting, dispensing volume and
workload in the pharmacy, the degree to which pharmacy
computer systems can help with problem identification,
true difference in problem rates in different locations,
and fluctuation in problem rates due to special local
circumstances or simple chance.
A negative correlation between dispensing volume and
problem reporting rates (or observed intervention rates) was
found in this study and previous studies (Rupp et al 1992;
Hawksworth et al 1999). It is plausible that as their
dispensing workload increases, pharmacists may find it more
difficult to report problems or make interventions.
Nevertheless, it should be noted that the interplay of the
factors mentioned above means that other explanations are
possible. Also, it should be noted that the correlation found
in our study was not particularly strong and no correlation
was identified in some other studies (Caleo et al 1996; van
Mil et al 2001).
Omission of prescriber’s signature and
other information
In this study, the most frequent prescribing problem relating
to incomplete prescriptions was lack of a prescriber’s
signature and there were similar findings in two other recent
studies carried out in the UK (Shah et al 2001; Quinlan et al
2002). As most prescriptions from British general practices
are now computer-generated, signing prescriptions is
currently the only step in the prescription-generating processTherapeutics and Clinical Risk Management 2005:1(4) 340
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that cannot be performed by a computer. The relative high
frequency of missing signatures in relation to other errors
of omission in these studies may be seen as indirect evidence
indicating the effectiveness of using computers to reduce
omission errors. The proposed electronic signatures for
prescriptions may further reduce this type of error
(Anonymous 2004).
Given the legal responsibility behind the act of signing
prescriptions, the significance of the omission of signatures
on prescriptions could depend on the underlying causes. If
the GP had checked the prescription but forgot to sign it
due to memory lapse, the error could be difficult to prevent
but nonetheless would not do much harm. If, however, the
GP overlooked a prescription when quickly checking
through a pile of prescriptions, the error could represent a
potential failure in the system which deserves further
attention. It was not possible, however, to determine the
actual underlying causes for the omission of signatures in
this study.
Benefits and pitfalls of computerized
prescribing
Computerized prescribing offers substantial benefits such
as speed, improved legibility, and automated record keeping.
Most of the omission errors mentioned above could be
prevented by making changes to computer systems to force
prescribers to provide all necessary information when
generating prescriptions. Having a single electronic medical
record shared by both primary and secondary care may also
reduce errors which occur when transcribing information
from hospital correspondence to general practice records.
On the other hand, the findings of this study also
highlight several potential pitfalls with computerized
prescribing. For instance, the use of “drop down menus”
means that it is possible to select the wrong drug from an
alphabetical list of preparations such as in the case of
betamethasone and beclomethasone, or select the wrong
patient from a list of similar names (Ferner and Coleman
2005). Several errors reported by the pharmacists illustrated
the possibility of incorrect or outdated instructions being
carried over to repeat prescriptions. These problems are
likely to occur for medications requiring initial loading doses
or involving regimens in which the doses are gradually built
up or stepped down. A further example raised in the group
discussion with GPs is the possibility of issuing a
prescription with the wrong patient’s name – and hence
generating an incorrect medication record – if the prescribing
doctor forgets to switch computer records between patients.
These cases demonstrate some limitations of computerized
prescribing in preventing errors and the importance of other
measures of error reduction and mitigation.
Sharing of information and
communication between GPs and
pharmacists
As described earlier, not all prescribing problems arise from
errors. Although pharmacists reported seventeen potentially
hazardous drug combinations, they contacted prescribers
in less than half of the cases and only one prescription was
subsequently altered. Virtually all the hazardous drug
combinations were associated with either increased risk of
toxicity or possible reduction of efficacy and none of them
were absolute contraindications, which would indicate an
error. These combinations usually require monitoring of
treatment and provision of additional advice to patients.
Community pharmacists are frequently confronted with
difficult situations in which information such as blood test
results or patients’ medical histories are not available to allow
assessment of medication safety. In these cases pharmacists
usually have to rely on their experience and information
from the patient to make a judgment about whether to contact
the prescriber for clarification. There is a strong argument
for community pharmacists having better access to relevant
patient information, which would allow them to monitor
drug therapy while reducing unnecessary contact with
prescribers. It is also possible that access to patients’ medical
history and biochemical data could increase the detection
of errors associated with prescribing decisions.
Among the nine reported problems related to
inappropriate doses, four of them involved medications for
children and in two of these cases the doses were
subsequently changed. The pharmacists appeared to
maintain high vigilance regarding medications for children.
Given the limited clinical information currently available
to pharmacists, attempts to differentiate between prescribing
errors in dosage and prescribers’ intentional use of
exceptional doses could be a major challenge. Similar
situations occur with potentially hazardous drug
combinations and potentially contraindicated medications
mentioned earlier. Unnecessary queries to prescribers could
delay the dispensing of the medication, undermine patients’
confidence, and increase workload for both the prescribers
and the pharmacists. However, taking no action without
prescribers’ assurance could put patients at risk of harm. ATherapeutics and Clinical Risk Management 2005:1(4) 341
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suggestion made by local pharmacists and GPs was that
GPs add a message to the prescriptions when knowingly
prescribing an unusual dose or potentially hazardous
drug(s). Pharmacists could then be more confident about
the appropriateness of the prescriptions and avoid
unnecessary queries.
Error defence by pharmacists and
patients
It has been suggested previously that prescribers’ decision
making processes vary (Denig et al 2002) and important
elements of prescribing can sometimes be ignored. In this
study, pharmacists elicited patients’ past history of adverse
drug reactions and drug allergy and the prescribers
subsequently changed prescriptions in two cases. This
pharmacist “safety net” remains an important mechanism
in preventing adverse drug events caused by errors. In other
cases, patients discussed potential adverse drug reactions
with the pharmacists, who assessed the potential benefit and
risk and provided advice to alleviate possible side effects.
The importance of patients themselves in detecting errors
at the final stage of medication use process cannot be
overstressed. Ensuring that patients have sufficient
understanding of their medications may also prevent errors
when they request repeat prescriptions or when they see a
different doctor.
Encouragement of error reporting and sharing of
information may help people to learn from previous errors
(Department of Health 2000). The simple method of data
collection adopted in this study and the collaboration of local
GPs and pharmacists provides a useful model for the primary
care setting.
Conclusion
The incidence of prescribing problems reported by
community pharmacists in this study was relatively low
compared with previous studies. Most of the prescribing
problems reported were attributable to errors in the
prescription-generating process. Lack of information on the
prescription and transcribing/typing errors were the most
frequently cited possible causes.
This study has illustrated the role that community
pharmacists have in the detection, rectification, and
prevention of prescribing problems. Future problems might
be prevented by improving communication and sharing of
information between GPs and pharmacists and by making
changes to the design of computerized prescribing systems.
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